TransCure bioServices Company

TransCure offers pre-clinical contract research services to pharmaceutical, biotech, start-up and academic researchers who need faster, smarter and cost-effective solutions for drug profiling. Uniquely designed animal models with functional humanized systems have been developed to provide predictive in vivo pharmacology testing in the field of inflammation, and autoimmune (IBD, RA, SLE, MS), anti-infective (HIV, EBV, CMV, Dengue), vaccine development, biosimilar and preclinical lead candidate selection / validation for drug development.

Their customer-oriented approach includes co-designing of experiments with customers to match their needs, diligently and carefully performing the ordered studies and providing comprehensive data analysis and reporting. They are also committed to the 3R principles “reduce, refine and replace” and carefully design the experiments to refine and reduce the use of experimental animals. Located in France, near Geneva, their state-of-the-art animal facilities (BSL 2&3) and scientific programs are ready to serve customers around the world for their faster access to market entrance.
Technology: P4 Medicine
Industry: P4 Medicine
Headquarters: Carouge, Geneve, Switzerland
Founded Date: 7-4
Employees Number: 1-10
Funding Status: Undisclosed
Investors Number: 3
Total Funding: $4M
Last Funding Type: Venture - Series Unknown

Visit Website
info@tcbiosciences.com
Register and Claim Ownership